ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $5,407,000 | -17.5% | 192,695 | 0.0% | 0.08% | -19.0% |
Q3 2021 | $6,550,000 | -74.5% | 192,695 | -69.4% | 0.10% | -74.1% |
Q2 2021 | $25,705,000 | +1.5% | 629,100 | 0.0% | 0.39% | -4.9% |
Q1 2021 | $25,328,000 | -24.7% | 629,100 | +10.5% | 0.41% | -28.8% |
Q4 2020 | $33,651,000 | +21.0% | 569,100 | -0.5% | 0.57% | +4.6% |
Q3 2020 | $27,816,000 | +192.6% | 571,990 | +191.1% | 0.54% | +183.9% |
Q2 2020 | $9,507,000 | +72.7% | 196,500 | -0.8% | 0.19% | +46.6% |
Q1 2020 | $5,504,000 | +80.5% | 198,120 | +94.3% | 0.13% | +142.6% |
Q4 2019 | $3,050,000 | +71.3% | 101,950 | +76.9% | 0.05% | +68.8% |
Q3 2019 | $1,781,000 | +5.4% | 57,630 | +64.7% | 0.03% | +6.7% |
Q2 2019 | $1,690,000 | – | 35,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
Triatomic Management LP | 130,805 | $999,350 | 0.84% |
Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |